SCHEMBL6026587

SCHEMBL6026587

CCCCc1ccc(C2OC(=O)C(O)=C2O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
LMNA P02545 2/20 0.42
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
ESR1 P03372 2/20 0.40
ADRA2A P08913 2/20 0.40
ADORA3 P0DMS8 2/20 0.40
TACR2 P21452 2/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SHBG P04278 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
HSPD1 P10809 1/20 0.40
ADRB3 P13945 1/20 0.40
HTR2C P28335 1/20 0.40
HSPE1 P61604 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28547883 0.70 SPHK1 (0.38) ALDH1A1HSD17B10HPGDCA2CA1
SCHEMBL83869 0.66 CA2 (0.65) ALDH1A1LMNAHSD17B10HPGDESR1
SCHEMBL28550292 0.66 PLA2G6 (0.42) ALDH1A1SLC6A3TP53CA2
SCHEMBL10692168 0.66 CYP1A2 (0.43) ALDH1A1HSD17B10HPGDTP53CA2
SCHEMBL20233 0.65 ESR1 (0.83) ALDH1A1LMNAHSD17B10HPGDESR1
Formaldehyde SCHEMBL305916 0.64 ESR1 (0.73) ALDH1A1LMNAHSD17B10HPGDESR1
Ammonia Solution, Strong SCHEMBL28990998 0.64 CA2 (0.62) ALDH1A1LMNAHSD17B10HPGDESR1
SCHEMBL9839955 0.64 CA2 (0.62) ALDH1A1LMNAHSD17B10HPGDESR1
SCHEMBL10568421 0.64 ALDH1A1 (0.65) ALDH1A1LMNAHSD17B10HPGDESR1
SCHEMBL10720546 0.64 THRA (0.47) ALDH1A1LMNAHSD17B10HPGDESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6010685-A SUNSCREEN AGENTS OXIS INTERNATIONAL, INC. (US) 2000-01-04 US claimed
US-7019029-B2 Skin whiteners containing hydroxytetronic acid derivatives THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT 2006-03-28 US disclosed
US-20020141956-A1 Skin whiteners containing hydroxytetronic acid derivatives THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY, AS ADMINISTRATIVE AGENT 2002-10-03 US disclosed
US-6010685-A SUNSCREEN AGENTS OXIS INTERNATIONAL, INC. (US) 2000-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020141956-A1 Skin whiteners containing hydroxytetronic acid derivatives TYR, PPP6C, CYP26A1 ALDH1A1 55/4885LMNA 3638/4885HSD17B10 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.